Related Experiment Videos
Hepatitis C virus and organ transplantation
J A Fishman1, R H Rubin, M J Koziel
1Transplantation Infectious Disease Unit, Massachusetts General Hospital, Boston 02114, USA.
Transplantation
|July 27, 1996
Summary
Hepatitis C virus (HCV) significantly impacts liver transplant recipients, causing progressive liver disease and limiting immune responses. Careful consideration of organs from HCV-positive donors is crucial for patient outcomes.
Area of Science:
- Hepatology
- Transplant Immunology
- Virology
Background:
- Hepatitis C virus (HCV) is a primary cause of cirrhosis and liver failure, necessitating liver transplantation.
- HCV infection affects approximately 10% of transplant recipients, leading to progressive liver disease 5-10 years post-transplant.
- HCV contributes to increased risks of opportunistic infections and hepatocellular carcinoma in transplant patients.
Purpose of the Study:
- To review the challenges and considerations of Hepatitis C virus (HCV) infection in organ transplantation.
- To discuss the implications of using organs from HCV-positive donors.
- To highlight areas for future research in HCV management post-transplant.
Main Methods:
- Literature review on HCV in transplant recipients.
- Analysis of viral factors influencing disease progression.
- Evaluation of current therapeutic strategies and organ donor selection.
Main Results:
- HCV genotypes and quasispecies diversity impede protective immunity.
- Interferon-alpha therapy shows limited efficacy in transplant patients.
- Organs from HCV-positive donors efficiently transmit the virus.
Conclusions:
- Organs from HCV-positive donors are currently best suited for patients with urgent transplant needs.
- Further research is needed on viral superinfection and the use of these organs in specific recipient populations (older, diabetic, sensitized).
- Balancing quality of life with long-term HCV impact is critical in decision-making.